Main author:


Work Package:

WP2 – Preparation for future RSV product assessment

PDF file

Understanding the real-life effectiveness of RSV products is of major public health importance. The PROMISE Consortium has developed two protocols for observational studies to assess preventive product (monoclonal antibody or vaccine) effectiveness: one using the test-negative design, the other, for cohort studies using electronic databases. These outputs are intended as generic protocols which can be adapted to specific settings and modified to account for local data availability.

Published On: July 6, 2023